How India hit 95% measles vaccine coverage: The inside story
Source Entity
Anonna Dutt
India has achieved a significant public health milestone, reaching 98% coverage for the first dose and 95% for both doses of the measles vaccine in 2025. A WHO/UNICEF report confirms that India is no longer among the countries with the highest number of unvaccinated children.
India's Landmark Achievement in Measles Immunization
India has reached a critical turning point in its public health trajectory, achieving a remarkable 98% coverage for the first dose of the measles vaccine and 95% for both doses in 2025. According to a recent report by WHO and UNICEF, this progress is a testament to decades of sustained effort in immunization infrastructure. Most notably, 2025 marks the first year that India has been removed from the list of countries with the highest number of unvaccinated children, signaling a systemic shift in the nation's ability to protect its youngest citizens from preventable diseases.
Surpassing Pre-Pandemic Benchmarks
To understand the magnitude of this achievement, it is essential to compare current figures with pre-pandemic levels. In 2019, India's coverage stood at 95% for a single dose and 84% for both doses. The jump to 95% for the second dose represents a significant leap in healthcare delivery and follow-up care. While much of the world is still struggling to recover immunization rates that plummeted during the COVID-19 pandemic, India has not only recovered but surpassed its previous benchmarks, demonstrating a resilient and scalable healthcare delivery model.
The Challenge of the Population Denominator
Despite the impressive percentages, the scale of India's population creates a unique challenge known as the "population denominator." Even a tiny percentage of unvaccinated children translates into a large absolute number; in 2025, approximately 4.53 lakh children still missed their measles vaccine. This highlight underscores the reality that in a country as populous as India, reaching the final few percentage points is the most difficult phase of any health campaign, as it requires reaching the most marginalized and remote populations.
The Science of Sero-conversion and Herd Immunity
From a clinical perspective, the drive toward 95% and beyond is not arbitrary. A critical factor in measles eradication is the rate of sero-conversion. Experts note that even if 100% of a population is vaccinated, roughly 15% of individuals may not sero-convert, meaning they do not develop the necessary antibodies to gain protection. Consequently, achieving near-universal coverage is the only way to ensure that enough of the population is actually immune to prevent community outbreaks and maintain herd immunity.
Global Context and Comparative Progress
India's success stands in stark contrast to the challenges faced by other nations. For example, Nigeria currently tops the list of countries with the lowest measles vaccine coverage, with 56% of its children—approximately 32 lakh—missing their first dose. The disparity between India's 98% first-dose coverage and Nigeria's struggle highlights the impact of successful national immunization strategies and the varying levels of healthcare stability across different global regions.
Future Outlook and Sustainability
Looking forward, the primary challenge for India will be the sustainability of these gains. The transition from being a country with a high volume of unvaccinated children to a leader in coverage requires continuous vigilance. The focus must now shift toward closing the gap for the remaining 4.53 lakh children and ensuring that the 95% dual-dose threshold is maintained or increased. This will likely require ongoing investment in cold-chain logistics and community-level health worker outreach to prevent any regression in these hard-won statistics.
Summary
India has successfully transitioned out of the high-risk group of countries with the most unvaccinated children, hitting 95% coverage for both measles doses in 2025. By surpassing its 2019 levels and addressing the complexities of sero-conversion and population scale, India has set a global example in public health recovery and immunization efficiency.